Registry of Lobbyists
Amgen Canada Inc.
Subject matters | Details | Categories |
---|---|---|
Science and Technology
|
Communicating, in general, with government officials about research, development and innovation in Canada's biomedical and biotechnology sector.
|
Policies or Program
|
Health, Taxation and Finance
|
Communicating with government officials about a national pharmaceutical strategy, more specifically as it relates to (i) enhanced access to orphan drugs and (i) incentives for the development of rare disorder treatments.
|
Policies or Program
|
Health, Labour
|
Communicating with government officials about federal healthcare plans and benefits.
|
Policies or Program
|
Health
|
Communicating with government officials about programs, reports, reviews and policies issued by or related to Canada's Drug Agency (formerly known as the Canadian Agency for Drugs and Technologies in Health).
|
Policies or Program
|
Health, Intellectual Property
|
Communicating with government officials about regulations, guidelines, reviews, references and reporting requirements issued by and/or related to the Patented Medicine Prices Review Board ("PMPRB").
|
Policies or Program
|
Health, Intellectual Property
|
Communicating with government officials about regulations related to patented medicines, including the "Patented Medicines (Notice of Compliance) Regulations" (SOR/93-133) under the Patent Act.
|
Regulation
|
Health
|
Communicating with government officials about the Food and Drugs Act, including about (i) the approval framework for drug products, such as subsequent entry biologics (also known as biosimilars), (ii) export and cross-border trade restrictions for drug products, (iii) data exclusivity for drug products, (iv) approvals (and subsequent reviews) for new drug submissions, and (v) post-market surveillance of drug products.
|
Legislative Proposal, Bill or Resolution
|
Science and Technology
|
Communicating with government officials about the Government of Canada's "Biomanufacturing and Life Sciences Strategy" (2021).
|
Policies or Program
|
Health, Science and Technology
|
Communicating with government officials about the pan-Canadian Health Data Strategy, more specifically about health data foundations.
|
Policies or Program
|